SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 13, 1998
----------------
FAIRMOUNT CHEMICAL CO., INC.
(Exact name of registrant as specified in its charter)
------------------------------------------------------
New Jersey 1-4591 22-0900720
- -----------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification)
117 Blanchard Street, Newark, New Jersey 07105
- -----------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (201) 344-5790
---------------
- -----------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events
On January 13, 1998, Mr. Todd K. Walker
resigned as President, Chief Executive Officer, Chairman of the Board
of Directors and as a director of Fairmount Chemical Co., Inc. (the
"Company"). Dr. Reidar Halle, a director of the Company, has been
retained to serve as Chief Executive Officer of the Company on an
interim basis until a President and Chief Executive Officer is chosen
by the Board. Mr. Howard R. Leistner, also a director of the
Company, has been appointed as Chairman of the Board.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 23, 1998
FAIRMOUNT CHEMICAL CO., INC.
(Registrant)
By: /s/ JAMES F. GILDAY
-------------------------
James F. Gilday
Chief Financial Officer
